MedPath

Agitation in Alzheimer's Disease

Phase 3
Completed
Conditions
Alzheimer Disease
Registration Number
NCT00000179
Lead Sponsor
National Institute on Aging (NIA)
Brief Summary

Agitation affects 70 to 90 percent of patients with AD. Signs of agitation include verbal and physical aggressiveness, irritability, wandering, and restlessness. These behaviors often make caring for patients at home very difficult. Trazodone and haldol are two of the most commonly prescribed drugs for agitation in AD patients. Behavior management, a non drug approach, has been effective in reducing signs of agitation. Researchers have yet to compare the effectiveness of drug versus non drug therapy to treat agitation in AD patients and determine which is the best treatment. The Alzheimer's Disease Cooperative Study, with funding from the National Institute on Aging, is conducting an agitation treatment program at 21 sites in 16 States. This study will assess which of the above treatments is most effective.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Memory problem consistent with a probable diagnosis of Alzheimer's disease (AD)
  • Agitation symptoms for at least the past 2 weeks
  • Patient has caregiver who can participate
  • Patient lives in the same household as the caregiver
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (16)

University of California, Los Angeles

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

University of California, San Diego

πŸ‡ΊπŸ‡Έ

San Diego, California, United States

University of Miami

πŸ‡ΊπŸ‡Έ

Miami, Florida, United States

University of South Florida

πŸ‡ΊπŸ‡Έ

Tampa, Florida, United States

Emory University

πŸ‡ΊπŸ‡Έ

Atlanta, Georgia, United States

Southern Illinois University

πŸ‡ΊπŸ‡Έ

Springfield, Illinois, United States

University of Kansas Medical Center

πŸ‡ΊπŸ‡Έ

Kansas City, Kansas, United States

University of Kentucky

πŸ‡ΊπŸ‡Έ

Lexington, Kentucky, United States

University of Massachusetts

πŸ‡ΊπŸ‡Έ

Worcester, Massachusetts, United States

University of Michigan

πŸ‡ΊπŸ‡Έ

Ann Arbor, Michigan, United States

Scroll for more (6 remaining)
University of California, Los Angeles
πŸ‡ΊπŸ‡ΈLos Angeles, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.